Please login to the form below

Not currently logged in
Email:
Password:

sembragiline

This page shows the latest sembragiline news and features for those working in and with pharma, biotech and healthcare.

Roche starts new late-stage trials of Alzheimer’s candidate

Roche starts new late-stage trials of Alzheimer’s candidate

Aside from gantenerumab, Roche has another iron in the fire for Alzheimer’s in the shape of crenezumab, another anti-amyloid antibody, but it was forced to abandon sembragiline - a drug

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics